Professor Helen Marshall AM, Dr Mark McMillan, Dr Vicki Krause, Dr Bing Wang with the 2025 Australian Infectious Diseases Research Centre Eureka Prize for Infectious Diseases Research.
University of Adelaide researchers have been recognised for their work in infectious diseases in this year's Australia Museum Eureka Prizes announced last week at the awards night in Sydney.
The Vaccines and Infectious Disease Group, led by Professor Helen Marshall, received the Australian Infectious Diseases Research Centre Eureka Prize for Infectious Diseases Research.
The Vaccines Group also features SA Pathology, the Department for Health and Wellbeing, SA Health, the Women's and Children's Hospital and Northern Territory Health.
"We have demonstrated that one vaccine can protect against both meningococcal B disease and gonorrhoea - two serious infections that disproportionately impact First Nations young people," says Professor Marshall.
"Our research has changed global vaccine policy, informed national programs and offers a new strategy to curb gonorrhoea as antibiotic resistance grows".
"There was strong competition from the Eastern states, so we're all thrilled that this work has been acknowledged nationally.
"It is also a great outcome for our NHMRC Centre for Research Excellence in Neisseria Disease Control, through which we aim to deliver a roadmap to eliminate meningitis and drive down gonorrhoea worldwide by effective targeted and national immunisation programs."
University of Adelaide Acting Deputy Vice-Chancellor and Vice-President (Research) Professor Laura Parry congratulated the team for its win.
"The University of Adelaide is extremely proud to be leading this outstanding research in vaccine development and national immunisation programs in partnership with the State's and Northern Territory's health service providers," says Professor Parry.
"Professor Marshall's research is delivering real-world positive health outcomes for people in Australia and across the world.
"It also highlights the power of research collaborations to accelerate translation of the ground-breaking research that our researchers produce."
